about
Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and diseaseMolecular Biology and Clinical Mitigation of Cancer Treatment-Induced NeuropathyRegulation of Dendritic Cell Function by Vitamin DVitamin D, multiple sclerosis and inflammatory bowel diseaseIs Multiple Sclerosis an Autoimmune Disease?Vitamin D and the intracrinology of innate immunity.Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitisIs hypovitaminosis D one of the environmental risk factors for multiple sclerosis?Vitamin D in health and disease: current perspectives.Clinical implications of a possible role of vitamin D in multiple sclerosisEffect of vitamin D3 supplementation on TNF-α serum level and disease activity index in Iranian IBD patients.Genetics and pathogenesis of multiple sclerosis.Why do T cells express the vitamin D receptor?Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosisSerum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.Sunshine, Sea, and Season of Birth: MS Incidence in WalesAvailability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responsesContribution of vitamin D insufficiency to the pathogenesis of multiple sclerosisAssociation between levels of vitamin D and inflammatory markers in healthy women.Vitamin D, invariant natural killer T-cells and experimental autoimmune diseaseGenetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis.Hypovitaminosis d in patients with type 2 diabetes mellitus: a relation to disease control and complications.Is serum vitamin D levels associated with disability in patients with newly diagnosed multiple sclerosis?Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases.Role of vitamin D in immune responses and autoimmune diseases, with emphasis on its role in multiple sclerosis.Vitamin d and metabolic syndrome risk factors: evidence and mechanisms.Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn?Oral vitamin D increases the frequencies of CD38+ human B cells and ameliorates IL-17-producing T cells.Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury.Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation.The prevalence of multiple sclerosis in 3 US communities: the role of vitamin D.Impaired T cell activation and cytokine production by calcitriol-primed human B cells.Epstein-Barr and other viral mimicry of autoantigens, myelin and vitamin D-related proteins and of EIF2B, the cause of vanishing white matter disease: massive mimicry of multiple sclerosis relevant proteins by the Synechococcus phage.UK food standards agency workshop report: diet and immune function.
P2860
Q24633922-254E0C45-5E70-4F12-9EF5-7BC04037B642Q26747796-DC214723-681E-40E6-8376-4CC52A55E1F8Q26781521-B935760B-5B70-40C2-883C-03AF9F68E1E6Q26865776-726D6C93-4E00-4D6D-97FC-08234D819B0AQ27496011-4BABB0F8-D633-4AFC-A13D-74424ECE7A69Q33787809-D3642538-CD36-4D81-931C-AC7E5376E069Q33874475-33A3FAC9-1EA3-47C9-8143-CEA75D6E8F4AQ34123145-13D41399-DE4C-4D5E-B8FF-137CB10D3A54Q34481617-6C39A703-0F75-4EA3-9EF2-5A52A18AAE06Q34607012-2A62D73B-CB8C-46B3-A279-535FEBECC7E1Q34852876-9BCE9788-5891-40CA-B97C-E323C1F816A4Q35004746-091929FD-D327-4910-AE59-72982F830A90Q35086363-A2905E90-A69A-479D-AE9C-16798EE34C04Q35231795-45F3C2C0-CCAE-4B71-8409-562FE1B2F35FQ35399451-F574440C-5FB6-412C-BE88-CB8C14B88442Q36018602-03C06774-5C2F-4958-8124-8647FFEB5038Q36418390-DBFDCDA3-914C-47A1-A5E7-FD16C8596964Q36638670-FABBF05C-AD1C-4D7F-A6E6-31428FBB81CDQ36862115-ECBB40BC-D7CC-4B27-830F-9302F0A99A44Q37069026-473CCABB-4CF2-4B62-A2D8-60EB3661817CQ37101431-76516734-BACB-4214-9507-2AEF787AE787Q37285909-1FAFCE41-35F3-4472-932D-5A6CA17CBEBBQ37311740-CA809EBC-EE49-4529-8AC0-D30CDFF0E30AQ37716897-D9F1B4DE-30DC-462F-8270-9A9702F30AAFQ37813014-86E73A83-3B25-4A07-AEF1-2D3E18DB7976Q37953480-41335575-376C-4CB0-9023-2C40BEFBE5C8Q38285779-21A48DCF-FAC5-40EC-9B18-CA77E0479B8FQ39300012-0AA9A7AA-9648-4E9D-95BB-1E8374AFFB6EQ41543377-DC1743A6-49D4-40A7-9114-A87D4737C43CQ42218324-8265E5F4-3BAC-4409-9B2F-8A32015CAC6EQ42735225-9E8C3E42-4A6F-4435-A7AF-1E826909A28AQ45221213-5457231A-823A-4892-AB40-0C59A54AB652Q50066373-1627095A-0E72-42B7-9888-832A55FF7E6CQ51841183-B278592D-3A5B-43B9-ABB7-9FCB15FD5809
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vitamin D and multiple sclerosis: an update.
@en
type
label
Vitamin D and multiple sclerosis: an update.
@en
prefLabel
Vitamin D and multiple sclerosis: an update.
@en
P2860
P921
P1433
P1476
Vitamin D and multiple sclerosis: an update.
@en
P2093
Margherita T Cantorna
P2860
P304
P356
10.1111/J.1753-4887.2008.00097.X
P433
10 Suppl 2
P577
2008-10-01T00:00:00Z